Thursday Jun 19, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Science & Technology Startup Nation

The earlier, the better: Maccabi partners with California startup on cancer detection

Project will make use of Maccabi KSM's anonymized Tipa Biobank and multi-omics data from PrognomiQ to create biomarkers designed to improve early detection as well as outcomes for cancer patients.

by  Noga Martin/ILH Startup Editor
Published on  06-22-2022 15:44
Last modified: 06-22-2022 15:44
The earlier, the better: Maccabi partners with California startup on cancer detectionGetty Images

A woman prepares to undergo a mammogram. Early detection is key to better cancer outcomes | Photo: Getty Images

Share on FacebookShare on Twitter

Maccabi Health Services' Kahn-Sagol-Maccabi (KSM) Research and Innovation Center has partnered with a California-based health tech startup to develop biomarkers for the early detection of colorectal, lung, pancreatic, and breast cancers, KSM announced Tuesday.

Follow Israel Hayom on Facebook, Twitter, and Instagram

KSM will be working with PrognomiQ, which is working to harness multi-omics data to transform the detection of cancers at an early stage.

The joint project will make use of Maccabi's Tipa Biobank, the largest biological bank in Israel. The Tipa Biobank is based on a nationwide population group, and includes more than 800,000 biological anonymized samples.

The Israeli data will be integrated with technology from PrognomiQ to create a biomarker platform to improve the early detection of these cancers as well as outcomes and care for cancer patients.

PrognomiQ's high-throughput approach allows for large-scale studies and the development of high sensitivity tests.

"Maccabi is paving the way for innovative research to better model a comprehensive, multi-dimensional, patient journey," said KSM head Dr. Tal Patalon.

"Interweaving the clinical course of diseases with the biological changes throughout time is the key to reaching a significant breakthrough in redefining diseases, and thus tailoring treatment and prevention specifically to each patient," Patalon added.

CEO of PrognomiQ Philip Ma called the collaboration with KSM "exciting."

"PrognomiQ's platform is unique in that it is taking a next-generation approach to broadly sample the proteomic, metabolome, epigenome, transcriptome and genome for biomarkers – and accomplishing this at large scale.  The resulting multi-omics data sets provide unparalleled levels of biological insights and novel biological content that could lead to transformative new approaches to diagnostics and therapy development," Ma explained.

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

Related Posts

OpenAI's Sora Turbo transforms text into instant video contentjacquesdurocher/Getty Images/iStockphoto

A secret AI startup in Tel Aviv got $30B: This Israeli-raised pioneer did it

by Erez Linn

Ilya Sutskever, who gained prominence as chief scientist at OpenAI where he helped develop the technology behind ChatGPT, departed the...

Data operations startup Matia secures $10.5M to streamline enterprise data managementCourtesy of Matia

Data operations startup Matia secures $10.5M to streamline enterprise data management

by Erez Linn

The Israeli founders secure $10.5M to streamline enterprise data management as part of the AI revolution.

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2MGetty Images/iStockphoto

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2M

by ILH Staff

Arieli EL, part of the Arieli group of companies, has announced the acquisition of a 59.1% stake in veteran cyber...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il